EUCTR2012-001709-26-CZ进行中（未招募）1 期
Randomized, double-blind, placebo-controlled clinical trial of Immodin immunological efficacy in healthy adult volunteers. - not available
Sevapharma,a.s.0 个研究点开始时间: 2012年5月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects must have signed an approved informed consent after full information
- •Subjects meet the conditions of healthy individuals or eventual blood donors.
- •Subjects in good health with no acute illness last 4 weeks.
- •Men and women aged 18 to 30 years.
- •Subjects meet the conditions of cellular immunity within the normal range.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subject with acute infectious diseases.
- •Subject with immunodeficiency, including allergic diseases (anamnestically).
- •Pregnant woman and breastfeeding (anamnestically).
- •Woman at fertile age without adequate contraception (barrier and hormonal) or without practicing sexual abstinence.
- •Subject allergic to any of the substances of the investigational medicinal product administered in clinical trial.
- •Inability of cooperation or irresponsibility.
- •Current participation in another clinical trial or in drug evaluation, within 4 weeks prior to study entry.
- •Known or suspected history of alcoholism or drug abuse.
- •Unwillingness to sign informed consent.
- •Dependents (eg conscripts, persons dependent on the researcher - such as subordinates, family members).
研究者
相似试验
已完成
2 期
Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patientsatex allergyInflammatory and Immune System - AllergiesLatex allergyACTRN12611000543987Allergy Service. Hospital Santiago Apostol28
进行中（未招募）
1 期
The aim of the study is to analyze whether the administration of a vaccine against COVID19 infection can reduce the symptoms of long COVID.nlike what happens with other respiratory viruses, in a significant proportion of patients who have suffered from the disease, general and multi-organ symptoms may persist for months, which has been called long COVIDEUCTR2021-003331-28-ESFelix Gutierrez Rodero776
进行中（未招募）
1 期
Clinical trial to evaluate the effect of Raltegravir intensification (1.200 mg QD) on the gut microbiota of chronically HIV-1 infected subject over timeHIV-1MedDRA version: 19.0Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2016-002722-36-ESFUNDACIÓ LLUITA CONTRA LA SIDA
进行中（未招募）
3 期
Placebo-controlled clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin in relation to placebo in the negative viral load of participants with SARS-CoV2 flu syndrome and who do not have an indication for hospitalizatioRBR-95yjmqHospital Santa Paula
招募中
4 期
Randomized, double-blind, placebo-controlled clinical trial of Jingu Zhitong Ningjiao in treatment of knee osteoarthritis with kidney deficiency and blood stasisknee osteoarthritisITMCTR2024000175The First Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin, China